Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227,306,614
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
174,874,615
-
Shares change
-
-21,385,977
-
Total reported value, excl. options
-
$172,644,460
-
Value change
-
-$19,949,532
-
Put/Call ratio
-
121%
-
Number of buys
-
39
-
Number of sells
-
38
-
Price
-
$0.9864
Institutional Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q3 2024
As of 30 Sep 2024 Gossamer Bio, Inc. - Common Stock (GOSS) had 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 174,874,615 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, Siren, L.L.C., VANGUARD GROUP INC, Octagon Capital Advisors LP, ARCH Venture Management, LLC, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Palo Alto Investors LP, Samsara BioCapital, LLC, and 683 Capital Management, LLC.
This table shows 118 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.